- In April 2024, Single Pass achieved a milestone with FDA clearance for its Kronos biopsy closure device, a Class II medical device. The Kronos device aims to simplify post-biopsy procedures, enhancing patient outcomes and operational efficiency for healthcare providers
- In May 2023, Argon Medical Devices launched the SuperCore Advantage semi-automatic biopsy instrument in the U.S. Designed for soft tissue biopsies, this innovative device combines precision and ease of use, streamlining procedures in diagnostic medicine
- In February 2023, TransMed7 revealed plans to introduce advanced ultrasound-guided biopsy devices. This development underscores their commitment to providing minimally invasive and accurate biopsy solutions for improved diagnostic accuracy
- In December 2022, Olympus finalized the acquisition of Odin Medical Ltd., a UK-based cloud-AI endoscopy company. Conducted via Keymed, its UK subsidiary, the move integrates AI-driven diagnostic tools into Olympus' portfolio, advancing healthcare imaging technology
- In November 2021, B. Braun and REVA Medical announced a partnership for the distribution of Fantom Encore, a bioresorbable scaffold for coronary interventions. Manufactured with REVA's Tyrocore material, distribution began in Germany and Switzerland, with plans for broader reach
- In June 2021, Saga Surgical, a Swedish company, introduced the Forsvall Needle, an innovative biopsy needle designed to reduce risks of sepsis or infection post-procedure. This advancement aligns with the growing focus on safety in diagnostic practices
Frequently Asked Questions
The market is segmented based on Global Biopsy Guns and Needles Market Segmentation, By Product Type (Disposable and Reusable), Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, and Others), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers, and Others) – Industry Trends and Forecast to 2032
.
The Global Biopsy Guns And Needles Market size was valued at USD 124.19 USD Million in 2024.
The Global Biopsy Guns And Needles Market is projected to grow at a CAGR of 3.88% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
